COMMUNIQUÉS West-GlobeNewswire

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
06/08/2025
Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to imdusiran Dr. Roger Sawhney joins the Arbutus Board of Directors following resignation of Anuj Hasija Dr [...]
FDA Petition to Ban Mercury Dental Fillings submitted by IAOMT and DAMS INC.
06/08/2025
LAKELAND, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) and the Dental Amalgam Mercury Solutions (DAMS INC) have joined forces to petition the Food and Drug [...]
Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
06/08/2025
CELEBRATION, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, [...]
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR AN ASSISTED-LIVING FACILITY IN SOUTH FLORIDA FOR A TOTAL CONSIDERATION OF $22 MILLION
06/08/2025
WEST PALM BEACH, FLORIDA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“ FOXO ” or the “ Company ”) announces that it has executed a non-binding acquisition agreement to acquire an [...]
Pure Harvest Corporate Group Eliminates All Debt and Enters New Phase of Strategic Growth
06/08/2025
GREENWOOD VILLAGE, Colo., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Pure Harvest Corporate Group, Inc. (OTC: PHCG), a diversified holding company focused on acquiring and revitalizing undervalued businesses, is pleased to [...]
Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference
06/08/2025
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have [...]
Glass House Brands to Host Second Quarter 2025 Conference Call on August 13, 2025
06/08/2025
LONG BEACH, Calif. and TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest- [...]
4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
06/08/2025
EMERYVILLE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Akebia Therapeutics to Present at Canaccord Genuity’s 45th Annual Growth Conference
06/08/2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced [...]
Cardurion Pharmaceuticals Completes Enrollment in Phase 2 CYCLE Trials Evaluating CRD-750, a Novel PDE9 inhibitor, in Heart Failure
06/08/2025
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ejection fraction (HFrEF [...]
Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference
06/08/2025
SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results
06/08/2025
PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
06/08/2025
Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the Positive FDA Meeting GLEN ALLEN, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals [...]
NEXGEL to Report Second Quarter 2025 Financial Results on August 12th
06/08/2025
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, [...]
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
06/08/2025
ARLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare [...]
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
06/08/2025
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 45 th [...]
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
06/08/2025
REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that [...]
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
06/08/2025
REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release [...]
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference
06/08/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates ( [...]

Pages